Register below for ANDHealth and Novartis’ “Digital Health: Clinical Evidence and Patient Impact”
Digital Health: Clinical Evidence and Patient Impact
Date: 3rd of May
Time: 9:30am – 11:30am
Location: 54 Waterloo Rd, Macquarie Park NSW
ANDHealth and Novartis are delighted to welcome international digital health leader Anand Iyer, Co-Founder & Chief Strategy Officer, WellDoc. Anand is most known for his insights and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes.
As a foundation member and ANDHealth’s exclusive pharmaceutical partner, Novartis is working with ANDHealth to advance the commercialisation of evidence-based digital health technologies in Australia, to change the way we deliver healthcare and to provide patients with better health outcomes.
Numbers are limited so register you and your team today.
Keynote Speaker: Anand Ayer PhD, MBA
Co-Founder & Chief Strategy Officer, WellDoc on “Crossing the Boundary Between Technology and Therapeutics”
|9:40 am -10.20 am||Keynote Address – Crossing the Boundary Between Technology and Therapeutics
Anand Iyer, Co-Founder & Chief Strategy Officer, WellDoc
|10.20 am – 10.45 am||Strengthening Australia’s digital health sector
Bronwyn Le Grice, Co-Founder, CEO & Managing Director, ANDHealth
|10.45 am – 11.05 am||Transforming healthcare through digital health – a tech and patient perspective|
|11.05 am – 11.20 am||The broader digital health landscape
Federico Girosi, Chief Scientist and Director of Research, Digital Health CRC
|11.20 am – 11.30 am||Australia’s National Digital Health Showcase|